v3.25.2
SCHEDULE OF OPTION ACTIVITY FOR BEYOND CANCER (Details) - 2021 Beyond Cancer Ltd Equity Incentive Plan [Member] - USD ($)
3 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Options, Outstanding at beginning of period 2,816,250  
Weighted Average Exercise Price - Options, Outstanding at beginning of period $ 5.50  
Weighted average remaining contractual life - options, outstanding at end of period 6 years 10 months 24 days 7 years 2 months 12 days
Aggregate Intrinsic Value, Outstanding at beginning of period  
Number of options outstanding, granted  
Weighted Average Exercise Price - Options, Granted  
Number of options outstanding, exercised  
Weighted Average Exercise Price - Options, Exercised  
Number of options outstanding, forfeited (404,250)  
Weighted Average Exercise Price - Options, Forfeited $ 5.50  
Number of Options, Outstanding at ending of period 2,412,000 2,816,250
Weighted Average Exercise Price - Options, Outstanding at ending of period $ 5.50 $ 5.50
Aggregate Intrinsic Value, Outstanding at end of period
Number of Options Outstanding, Exercisable 1,504,000  
Weighted Average Exercise Price - Options, Exercisable $ 5.50  
Weighted average remaining contractual life - options, exercisable 6 years 9 months 18 days  
Aggregate intrinsic value, exercisable